The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
OLIGOPELVIS – GETUG P07, a multicentre phase II trial of combined salvage radiotherapy and hormone therapy in oligometastatic pelvic node relapses of prostate cancer: Preplanned analysis of acute toxicity.
 
Stephane Supiot
Employment - Astellas Pharma; Ferring; Janssen-Cilag
Leadership - Ipsen; Sanofi
Research Funding - Astellas Pharma (Inst); Janssen-Cilag (Inst)
Travel, Accommodations, Expenses - Ipsen
 
Gilles Crehange
Consulting or Advisory Role - Ferring
Travel, Accommodations, Expenses - Ipsen
 
Xavier Buthaud
No Relationships to Disclose
 
David Pasquier
Consulting or Advisory Role - Astellas Pharma
Travel, Accommodations, Expenses - Astellas Pharma; Ipsen
 
Ali Hasbini
No Relationships to Disclose
 
Guy De Laroche
No Relationships to Disclose
 
Pascal Pommier
No Relationships to Disclose
 
Genevieve Loos
No Relationships to Disclose
 
Veronique Beckendorf
No Relationships to Disclose
 
Paul Sargos
No Relationships to Disclose
 
Emmanuel Rio
No Relationships to Disclose
 
Loic Campion
No Relationships to Disclose